VWM
AZN icon

Vermillion Wealth Management’s AstraZeneca AZN Stock Holding History

Vermillion Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.45K Hold
34
– – ﹤0.01% 1315
2026
Q1 		$6.83K Hold
34
– – ﹤0.01% 444
2025
Q4 		$6.25K Hold
34
– – ﹤0.01% 425
2025
Q3 		$5.22K Buy
+34
New +$5.15K ﹤0.01% 1276

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vermillion Wealth Management's AZN Position: Q2 2026 in Review

Vermillion Wealth Management held its AstraZeneca (AZN) position steady in Q2 2026 at 34 shares worth $6.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

Vermillion Wealth Management first reported a position in AZN in Q3 2025 and has held it in 4 quarters since. The position peaked at $6.83K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Vermillion Wealth Management held 34 shares of AstraZeneca worth $6.45K as of Q2 2026.
  • Vermillion Wealth Management left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up ﹤0.01% of Vermillion Wealth Management's portfolio in Q2 2026, its #1315 holding.
  • Vermillion Wealth Management first reported a position in AstraZeneca in Q3 2025 and has held it in 4 quarters since.
  • Vermillion Wealth Management's AstraZeneca position peaked at $6.83K in Q1 2026.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Vermillion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.